This November, we’re “All In” for #NationalEpilepsyAwarenessMonth 📢

Register for our upcoming CME-accredited program and learn how to enhance outcomes in Lennox-Gastaut Syndrome, a form of epilepsy often lesser-known in clinical practice.

Sign up now to be notified upon release: go.sn.pub/hvtv6a

#WorldDiabetesDay 2025: Are you up to date with the latest advancements in ketone monitoring?

Dive into our complete Ketone Monitoring Masterclass to enhance your understanding of the latest guidelines in ketone monitoring for diabetes management.

Register now: go.sn.pub/15wcys

Have you secured your place on our upcoming webinar, ‘NTRK fusion-positive NSCLC: perspectives from pathology, oncology, and beyond’ yet? Join the experts on Tuesday 11 November to get key updates and insights, including first-hand patient experience from Stevan Bradford: go.sn.pub/hm0oyw

Getting ready to attend #ASH2025? Catch up on updates from EHA 2025 to prepare, including expert interviews, news from the congress, and a clinical commentary on the potential for rapid manufacturing of CAR-T cell therapies.

Access the insights: go.sn.pub/24sonc

Ready for AASLD’s #TLM25 this weekend? Our experts are sharing what they’re looking out for in rare liver disorders.

Access their insights and register to be notified of key updates from the meeting here: go.sn.pub/yevs6l

This Lung Cancer Awareness Month, take the opportunity to explore our extended eLearning course in biomarker-driven management of NSCLC.

Join our case-based webinar on November 11 to hear expert perspectives on the latest in NTRK fusion-positive NSCLC.

Register for free: go.sn.pub/lw8tim
#LCAM25

Explore this simulation-based module, bringing shared decision-making to life in the context of biomarker use in Alzheimer’s disease.

Dr Chuck Vega demonstrates the key principles of SDM alongside his mother, drawing on their family’s experience with AD: bit.ly/49pnBo3

Looking for key updates on NTRK fusion-positive NSCLC? Join our experts on 11 November, as they discuss the latest developments in the disease, including new data and recommendations presented at #ESMO25

Secure your place for free today: nsclc-biomarkers-ime.springermedicine.com/ntrk-webinar...

As #ESMO25 draws to a close, continue your learning on targeted therapies with the AML Expert Series. Hosted by Prof. Amer Zeidan of @yalecancer.bsky.social, this podcast series is designed to enhance your knowledge of IDH-mutant R/R AML. Tune in now: bit.ly/47lss7b

Do you manage patients with generalized myasthenia gravis?

Access this expert-led program, complete with CME-accredited video podcasts and downloadable resources, designed to help you improve your patient care: bit.ly/3W9rhTk

Are you looking for key updates on NTRK fusion-positive NSCLC? Our experts discuss the latest updates, including their perspectives on detection, treatment, and real-world challenges in this live webinar, including updates from ESMO 2025:
nsclc-biomarkers-ime.springermedicine.com/case-based-w...

Are you at #EASD2025? Head to our booth to find out more about our program in ketone monitoring!

Are you a healthcare professional looking for free, CME-accredited independent medical education from a trusted provider?

Follow us to stay up to date with our programs, spanning a wide selection of therapy areas 🤝

Springer Health+ IME are now on Bluesky!

Follow our page to stay up to date with key updates, hear more about our projects, learn more about the team, and more 🚀